Janus Henderson Group’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $113M | Sell |
|
|||||
|
2025
Q2 | $98.5M | Sell |
|
|||||
|
2025
Q1 | $109M | Sell |
|
|||||
|
2024
Q4 | $148M | Buy |
|
|||||
|
2024
Q3 | $175M | Buy |
|
|||||
|
2024
Q2 | $187M | Buy |
|
|||||
|
2024
Q1 | $218M | Buy |
|
|||||
|
2023
Q4 | $157M | Buy |
|
|||||
|
2023
Q3 | $110M | Buy |
|
|||||
|
2023
Q2 | $124M | Buy |
|
|||||
|
2023
Q1 | $62.5M | Buy |
|
|||||
|
2022
Q4 | $8.63M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $9.63M | Buy |
|
|||||
|
2021
Q4 | $8.12M | Buy |
|
|||||
|
2021
Q3 | $7.94M | Buy |
|
|||||
|
2021
Q2 | $5M | Buy |
|
|||||
|
2021
Q1 | $2.3M | Buy |
|
|||||
|
2020
Q4 | $1.54M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $22.6M | Sell |
|
|||||
|
2017
Q2 | $24.1M | Buy |
|